MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Malignant neoplasm of unspecified kidney, except renal pelvis (C64.9)

HealthDay 11 July at 04.04 PM

GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D

For patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine

HealthDay 31 January at 04.49 PM

Pembrolizumab Shows Survival Benefit for Patients With Renal Cancer

For patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months, according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Jan. 25 to 27 in San Francisco.Ton

HealthDay 11 January at 06.16 PM

End-of-Life Treatment With Immunotherapy Increasing for Patients With Cancer

Initiation of immunotherapy for metastatic cancer at the end of life (EOL) is increasing over time, according to a study published online Jan. 4 in JAMA Oncology.Daniel M. Kerekes, M.D., from Yale University in New Haven, Connecticut, and colleagues examined patient characteristics, practice patterns, and risk factors concerning